{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:56:56Z","timestamp":1775577416390,"version":"3.50.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15786-w","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T02:24:12Z","timestamp":1772418252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Significance of nodal yield after rectal resection in the TNT era: does count matter?"],"prefix":"10.1186","volume":"26","author":[{"given":"L. V.","family":"O\u2019Connell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Murnaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cowzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Aird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"O\u2019Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. C.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"5","key":"15786_CR1","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1046\/j.1463-1318.2003.00522.x","volume":"5","author":"D Sebag-Montefiore","year":"2003","unstructured":"Sebag-Montefiore D. Treatment of T4 tumours: the role of radiotherapy. Colorectal Dis. 2003;5(5):432\u20135.","journal-title":"Colorectal Dis"},{"issue":"2","key":"15786_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/codi.13550","volume":"19","author":"Z Lakkis","year":"2017","unstructured":"Lakkis Z, Manceau G, Bridoux V, Brouquet A, Kirzin S, Maggiori L, et al. Management of rectal cancer: the 2016 French guidelines. Colorectal Dis. 2017;19(2):115\u201322.","journal-title":"Colorectal Dis"},{"issue":"4","key":"15786_CR3","first-page":"326","volume":"23","author":"S Bedrikovetski","year":"2024","unstructured":"Bedrikovetski S, Traeger L, Seow W, Dudi-Venkata NN, Selva-Nayagam S, Penniment M, et al. Oncological outcomes and response rate after total neoadjuvant therapy for locally advanced rectal cancer: A network meta-analysis comparing induction vs. Consolidation chemotherapy vs. Standard chemoradiation. Clin Colorectal Cancer. 2024;23(4):326\u2013e3369.","journal-title":"Clin Colorectal Cancer"},{"issue":"31","key":"15786_CR4","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.2016.67.6049","volume":"34","author":"JH Lefevre","year":"2016","unstructured":"Lefevre JH, Mineur L, Kotti S, Rullier E, Rouanet P, de Chaisemartin C, et al. Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: A multicenter, randomized, controlled trial (GRECCAR-6). J Clin Oncol. 2016;34(31):3773\u201380.","journal-title":"J Clin Oncol"},{"issue":"2","key":"15786_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.radonc.2015.04.003","volume":"115","author":"J-P G\u00e9rard","year":"2015","unstructured":"G\u00e9rard J-P, Chamorey E, Gourgou-Bourgade S, Benezery K, de Laroche G, Mah\u00e9 M-A, et al. Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12\/PRODIGE 2 randomized trial. Radiother Oncol. 2015;115(2):246\u201352.","journal-title":"Radiother Oncol"},{"issue":"4","key":"15786_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","volume":"240","author":"A Habr-Gama","year":"2004","unstructured":"Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Silva e Sousa AH, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy. Ann Surg. 2004;240(4):711\u20138.","journal-title":"Ann Surg"},{"issue":"5","key":"15786_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1463-1318.2005.00864.x","volume":"7","author":"S Del Biondo","year":"2005","unstructured":"Biondo S, Navarro M, Marti-Rague J, Arriola E, Pares D, Del Rio C, et al. Response to neoadjuvant therapy for rectal cancer: influence on long-term results. Colorectal Dis. 2005;7(5):472\u20139.","journal-title":"Colorectal Dis"},{"issue":"3","key":"15786_CR8","first-page":"369","volume":"24","author":"O Ayd\u0131n","year":"2025","unstructured":"Ayd\u0131n O, \u00d6zt\u00fcrk AE, Erciyestepe M, Sonu\u015fen \u015eD, \u0130\u015fleyen ZS, Din\u00e7er ST, et al. The effect of total neoadjuvant treatment on pathological response and survival in locally advanced rectal cancer: A single center experience. Clin Colorectal Cancer. 2025;24(3):369\u2013e3771.","journal-title":"Clin Colorectal Cancer"},{"key":"15786_CR9","first-page":"31","volume-title":"Transanal Minimally Invasive Surgery (TAMIS) and Transanal Total Mesorectal Excision (taTME)","author":"LM Fernandez","year":"2019","unstructured":"Fernandez LM, S\u00e3o Juli\u00e3o GP, Vailati BB, Habr-Gama A, Perez RO. Complete clinical response in rectal cancer after neoadjuvant therapy: Organ preservation strategies and the role of surgery. Transanal Minimally Invasive Surgery (TAMIS) and Transanal Total Mesorectal Excision (taTME). Cham: Springer International Publishing; 2019. pp. 31\u201341."},{"issue":"10139","key":"15786_CR10","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","volume":"391","author":"MJM van der Valk","year":"2018","unstructured":"van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537\u201345.","journal-title":"Lancet"},{"issue":"5","key":"15786_CR11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/codi.16056","volume":"24","author":"SP Bach","year":"2022","unstructured":"Bach SP, Collaborative STAR-TREC. Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II\/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches. Colorectal Dis. 2022;24(5):639\u201351.","journal-title":"Colorectal Dis"},{"key":"15786_CR12","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines Version 2.2025 Rectal Cancer. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?id=1461."},{"issue":"3","key":"15786_CR13","first-page":"238","volume":"23","author":"DDG Bugano","year":"2024","unstructured":"Bugano DDG, Santos VM, Campos-Bragagnoli A, Melo JCM, Romagnolo LGC, Barbosa Neto O, et al. Brazil-TNT: A randomized phase 2 trial of neoadjuvant chemoradiation followed by FOLFIRINOX versus chemoradiation for stage II\/III rectal cancer. Clin Colorectal Cancer. 2024;23(3):238\u201344.","journal-title":"Clin Colorectal Cancer"},{"issue":"3","key":"15786_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/SLA.0000000000003471","volume":"271","author":"F Petrelli","year":"2020","unstructured":"Petrelli F, Trevisan F, Cabiddu M, Sgroi G, Bruschieri L, Rausa E, et al. Total neoadjuvant therapy in rectal cancer: A systematic review and meta-analysis of treatment outcomes. Ann Surg. 2020;271(3):440\u20138.","journal-title":"Ann Surg"},{"issue":"12","key":"15786_CR15","doi-asserted-by":"publisher","first-page":"e2030097","DOI":"10.1001\/jamanetworkopen.2020.30097","volume":"3","author":"A Kasi","year":"2020","unstructured":"Kasi A, Abbasi S, Handa S, Al-Rajabi R, Saeed A, Baranda J, et al. Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: A systematic review and meta-analysis. JAMA Netw Open. 2020;3(12):e2030097.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"15786_CR16","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1111\/codi.15873","volume":"23","author":"A Spinelli","year":"2021","unstructured":"Spinelli A, Carvello M. A surgical perspective on total neoadjuvant therapy for rectal cancer: Shades and lights of a new journey. Colorectal Dis. 2021;23(9):2223\u20134.","journal-title":"Colorectal Dis"},{"issue":"5","key":"15786_CR17","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset J-F, Etienne P-L, Rio E, Fran\u00e7ois \u00c9, Mesgouez-Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702\u201315.","journal-title":"Lancet Oncol"},{"issue":"1","key":"15786_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM-K, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29\u201342.","journal-title":"Lancet Oncol"},{"issue":"114291","key":"15786_CR19","doi-asserted-by":"publisher","first-page":"114291","DOI":"10.1016\/j.ejca.2024.114291","volume":"210","author":"E Fokas","year":"2024","unstructured":"Fokas E, Williams H, Diefenhardt M, Lin S, Qin L-X, Piso P, et al. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO\/ARO\/AIO-12 and the OPRA randomized phase 2 trials. Eur J Cancer. 2024;210(114291):114291.","journal-title":"Eur J Cancer"},{"issue":"10","key":"15786_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","volume":"35","author":"T Conroy","year":"2024","unstructured":"Conroy T, Castan F, Etienne P-L, Rio E, Mesgouez-Nebout N, Evesque L, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol. 2024;35(10):873\u201381.","journal-title":"Ann Oncol"},{"issue":"4","key":"15786_CR21","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1097\/SLA.0000000000005799","volume":"278","author":"EA Dijkstra","year":"2023","unstructured":"Dijkstra EA, Nilsson PJ, Hospers GAP, Bahadoer RR, Meershoek-Klein Kranenbarg E, Roodvoets AGH, et al. Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: A 5-year follow-up of the RAPIDO trial: A 5-year follow-up of the RAPIDO trial. Ann Surg. 2023;278(4):e766\u201372.","journal-title":"Ann Surg"},{"issue":"5","key":"15786_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1200\/JCO.23.01208","volume":"42","author":"FS Verheij","year":"2024","unstructured":"Verheij FS, Omer DM, Williams H, Lin ST, Qin L-X, Buckley JT, et al. Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: The randomized phase II OPRA trial. J Clin Oncol. 2024;42(5):500\u20136.","journal-title":"J Clin Oncol"},{"issue":"1","key":"15786_CR23","first-page":"45","volume":"21","author":"D Johnson","year":"2022","unstructured":"Johnson D, Li L, Lee K-C, Lam KO, Wong KH, Ho WM, et al. Total Neoadjuvant Therapy for high risk rectal cancer in Western and Asian populations - current evidence and clinical applications. Clin Colorectal Cancer. 2022;21(1):45\u201354.","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"15786_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/1066896914534464","volume":"22","author":"BD Hayes","year":"2014","unstructured":"Hayes BD, O\u2019Riordan JM, Stuart C, Muldoon C. Rectal site and suboptimal nodal yield predict systemic recurrence in resected colorectal carcinoma: a case-control study: A case-control study. Int J Surg Pathol. 2014;22(6):505\u201311.","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"15786_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1463-1318.2007.01225.x","volume":"10","author":"MD Evans","year":"2008","unstructured":"Evans MD, Barton K, Rees A, Stamatakis JD, Karandikar SS. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes\u2019 stage B disease. Colorectal Dis. 2008;10(2):157\u201364.","journal-title":"Colorectal Dis"},{"issue":"4","key":"15786_CR26","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<666::AID-CNCR6>3.0.CO;2-I","volume":"83","author":"S Caplin","year":"1998","unstructured":"Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes\u2019 B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer. 1998;83(4):666\u201372.","journal-title":"Cancer"},{"issue":"2","key":"15786_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ejca.2004.10.010","volume":"41","author":"L Sarli","year":"2005","unstructured":"Sarli L, Bader G, Iusco D, Salvemini C, Mauro DD, Mazzeo A, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer. 2005;41(2):272\u20139.","journal-title":"Eur J Cancer"},{"issue":"1","key":"15786_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1245\/ASO.2003.03.058","volume":"10","author":"RS Swanson","year":"2003","unstructured":"Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10(1):65\u201371.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"15786_CR29","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1097\/DCR.0b013e3182536d70","volume":"55","author":"ED Miller","year":"2012","unstructured":"Miller ED, Robb BW, Cummings OW, Johnstone PAS. The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer. Dis Colon Rectum. 2012;55(9):1002\u20137.","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"15786_CR30","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1097\/SLA.0000000000005051","volume":"275","author":"MB Loughrey","year":"2022","unstructured":"Loughrey MB, Webster F, Arends MJ, Brown I, Burgart LJ, Cunningham C, et al. Dataset for pathology reporting of colorectal cancer: Recommendations from the International Collaboration on Cancer Reporting (ICCR). Ann Surg. 2022;275(3):e549\u201361.","journal-title":"Ann Surg"},{"issue":"10","key":"15786_CR31","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.5858\/133.10.1539","volume":"133","author":"MK Washington","year":"2009","unstructured":"Washington MK, Berlin J, Branton P, Burgart LJ, Carter DK, Fitzgibbons PL, et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med. 2009;133(10):1539\u201351.","journal-title":"Arch Pathol Lab Med"},{"key":"15786_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejca.2016.10.031","volume":"72","author":"R Mechera","year":"2017","unstructured":"Mechera R, Schuster T, Rosenberg R, Speich B. Lymph node yield after rectal resection in patients treated with neoadjuvant radiation for rectal cancer: A systematic review and meta-analysis. Eur J Cancer. 2017;72:84\u201394.","journal-title":"Eur J Cancer"},{"issue":"1","key":"15786_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/PAS.0b013e3180dc92ab","volume":"32","author":"A Rullier","year":"2008","unstructured":"Rullier A, Laurent C, Capdepont M, Vendrely V, Belleann\u00e9e G, Bioulac-Sage P, et al. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol. 2008;32(1):45\u201350.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"15786_CR34","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11605-012-1916-4","volume":"16","author":"DC Damin","year":"2012","unstructured":"Damin DC, Rosito MA, Contu PC, Tarta C, Ferreira PR, Kliemann LM, et al. Lymph node retrieval after preoperative chemoradiotherapy for rectal cancer. J Gastrointest Surg. 2012;16(8):1573\u201380.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"15786_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.amjsurg.2012.10.020","volume":"205","author":"R Amajoyi","year":"2013","unstructured":"Amajoyi R, Lee Y, Recio PJ, Kondylis PD. Neoadjuvant therapy for rectal cancer decreases the number of lymph nodes harvested in operative specimens. Am J Surg. 2013;205(3):289\u201392. discussion 292.","journal-title":"Am J Surg"},{"issue":"4","key":"15786_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ejso.2009.12.006","volume":"36","author":"B Morcos","year":"2010","unstructured":"Morcos B, Baker B, Al Masri M, Haddad H, Hashem S. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy. Eur J Surg Oncol. 2010;36(4):345\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"15786_CR37","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.surg.2022.01.041","volume":"172","author":"JT Bliggenstorfer","year":"2022","unstructured":"Bliggenstorfer JT, Ginesi M, Steinhagen E, Stein SL. Lymph node yield after rectal resection is a predictor of survival among patients with node-negative rectal adenocarcinoma. Surgery. 2022;172(5):1292\u20139.","journal-title":"Surgery"},{"issue":"9","key":"15786_CR38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/DCR.0000000000000429","volume":"58","author":"J Lykke","year":"2015","unstructured":"Lykke J, Jess P, Roikjaer O, Danish Colorectal Cancer Group. Increased lymph node yield is associated with improved survival in rectal cancer irrespective of neoadjuvant treatment: Results from a national cohort study: Results from a national cohort study. Dis Colon Rectum. 2015;58(9):823\u201330.","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"15786_CR39","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/bjs.10218","volume":"103","author":"M Raoof","year":"2016","unstructured":"Raoof M, Nelson RA, Nfonsam VN, Warneke J, Krouse RS. Prognostic significance of lymph node yield in ypN0 rectal cancer: Rectal cancer and lymph node number. Br J Surg. 2016;103(12):1731\u20137.","journal-title":"Br J Surg"},{"issue":"8","key":"15786_CR40","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.ejso.2018.04.007","volume":"44","author":"M Degiuli","year":"2018","unstructured":"Degiuli M, Arolfo S, Evangelista A, Lorenzon L, Reddavid R, Staudacher C, et al. Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network (SICO-CCN) multicentre collaborative study. Eur J Surg Oncol. 2018;44(8):1233\u201340.","journal-title":"Eur J Surg Oncol"},{"key":"15786_CR41","doi-asserted-by":"publisher","first-page":"8037","DOI":"10.2147\/CMAR.S328666","volume":"13","author":"Y-M Lin","year":"2021","unstructured":"Lin Y-M, Chou C-L, Kuo Y-H, Wu H-C, Tsai C-J, Ho C-H, et al. Optimal lymph node yield for survival prediction in rectal cancer patients after neoadjuvant therapy. Cancer Manag Res. 2021;13:8037\u201347.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"15786_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.21037\/jgo.2018.10.02","volume":"10","author":"DKH Chan","year":"2019","unstructured":"Chan DKH, Tan K-K. Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance. J Gastrointest Oncol. 2019;10(1):42\u20137.","journal-title":"J Gastrointest Oncol"},{"issue":"6","key":"15786_CR43","doi-asserted-by":"publisher","first-page":"946","DOI":"10.21037\/jgo.2016.09.03","volume":"7","author":"J Gurawalia","year":"2016","unstructured":"Gurawalia J, Dev K, Nayak SP, Kurpad V, Pandey A. Less than 12 lymph nodes in the surgical specimen after neoadjuvant chemo-radiotherapy: an indicator of tumor regression in locally advanced rectal cancer? J Gastrointest Oncol. 2016;7(6):946\u201357.","journal-title":"J Gastrointest Oncol"},{"issue":"6","key":"15786_CR44","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1245\/s10434-014-4235-z","volume":"22","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Jo JS, Lee SY, Kim CH, Kim YJ, Kim HR. Low lymph node retrieval after preoperative chemoradiation for rectal cancer is associated with improved prognosis in patients with a good tumor response. Ann Surg Oncol. 2015;22(6):2075\u201381.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"15786_CR45","first-page":"e191","volume":"18","author":"HG Lee","year":"2019","unstructured":"Lee HG, Kim SJ, Park IJ, Hong SM, Lim S-B, Lee JB, et al. Effect of responsiveness of lymph nodes to preoperative chemoradiotherapy in patients with rectal cancer on prognosis after radical resection. Clin Colorectal Cancer. 2019;18(2):e191\u20139.","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"15786_CR46","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/his.15134","volume":"84","author":"SK Ozturk","year":"2024","unstructured":"Ozturk SK, Martinez CG, Mens D, Verhoef C, Tosetto M, Sheahan K, et al. Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer. Histopathology. 2024;84(6):935\u201346.","journal-title":"Histopathology"},{"issue":"28","key":"15786_CR47","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1200\/JCO.24.01160","volume":"42","author":"AJ Scott","year":"2024","unstructured":"Scott AJ, Kennedy EB, Berlin J, Brown G, Chalabi M, Cho MT, et al. Management of locally advanced rectal cancer: ASCO guideline. J Clin Oncol. 2024;42(28):3355\u201375.","journal-title":"J Clin Oncol"},{"key":"15786_CR48","unstructured":"Royal College of Pathologists. Dataset for histopathological reporting of colorectal cancer - September 2018 [Internet]. [cited 2025 July 15]. Available from: https:\/\/www.rcpath.org\/static\/c8b61ba0-ae3f-43f1-85ffd3ab9f17cfe6\/G049-Dataset-for-histopathological-reporting-of-colorectal-cancer.pdf."},{"issue":"4","key":"15786_CR49","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00428-021-03108-3","volume":"479","author":"G Chotard","year":"2021","unstructured":"Chotard G, Capdepont M, Denost Q, Smith D, Vendrely V, Rullier E, et al. Effects of neoadjuvant chemotherapy plus chemoradiotherapy on lymph nodes in rectal adenocarcinoma. Virchows Arch. 2021;479(4):657\u201366.","journal-title":"Virchows Arch"},{"issue":"3","key":"15786_CR50","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.surge.2024.03.001","volume":"22","author":"PW Owens","year":"2024","unstructured":"Owens PW, Saeed M, McCawley N, Loughlin P, Kearney DE, Burke JP, et al. Prolonged interval to surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A meta-analysis of randomized controlled trials. Surgeon. 2024;22(3):166\u201373.","journal-title":"Surgeon"},{"issue":"10","key":"15786_CR51","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/bjs.11220","volume":"106","author":"\u00c9J Ryan","year":"2019","unstructured":"Ryan \u00c9J, O\u2019Sullivan DP, Kelly ME, Syed AZ, Neary PC, O\u2019Connell PR, et al. Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer: Interval after chemoradiotherapy before surgery in locally advanced rectal cancer. Br J Surg. 2019;106(10):1298\u2013310.","journal-title":"Br J Surg"},{"issue":"9","key":"15786_CR52","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.ejso.2019.04.016","volume":"45","author":"AM van der Couwenberg","year":"2019","unstructured":"Couwenberg AM, Intven MPW, Hoendervangers S, van der Sluis FJ, van Westreenen HL, Marijnen CAM, et al. The effect of time interval from chemoradiation to surgery on postoperative complications in patients with rectal cancer. Eur J Surg Oncol. 2019;45(9):1584\u201391.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"15786_CR53","first-page":"378","volume":"24","author":"J Zhao","year":"2025","unstructured":"Zhao J, Huang K, Zhu A, Zhu J, Fang Y, Zhou X, et al. MRI monitoring of locally advanced rectal cancer in watch and wait patients. Clin Colorectal Cancer. 2025;24(3):378\u2013e3885.","journal-title":"Clin Colorectal Cancer"},{"issue":"1","key":"15786_CR54","first-page":"13","volume":"17","author":"D Du","year":"2018","unstructured":"Du D, Su Z, Wang D, Liu W, Wei Z. Optimal interval to surgery after neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis. Clin Colorectal Cancer. 2018;17(1):13\u201324.","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"15786_CR55","doi-asserted-by":"publisher","first-page":"e180071","DOI":"10.1001\/jamaoncol.2018.0071","volume":"14","author":"A Cercek","year":"2018","unstructured":"Cercek A, Roxburgh CSD, Strombom P, Smith JJ, Temple LKF, Nash GM, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 2018;14(6):e180071.","journal-title":"JAMA Oncol"},{"issue":"114044","key":"15786_CR56","doi-asserted-by":"publisher","first-page":"114044","DOI":"10.1016\/j.ejca.2024.114044","volume":"204","author":"WH Zwart","year":"2024","unstructured":"Zwart WH, Temmink SJD, Hospers GAP, Marijnen CAM, Putter H, Nagtegaal ID, et al. Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial. Eur J Cancer. 2024;204(114044):114044.","journal-title":"Eur J Cancer"},{"issue":"12","key":"15786_CR57","doi-asserted-by":"publisher","first-page":"7476","DOI":"10.1245\/s10434-021-09837-8","volume":"28","author":"JC Kong","year":"2021","unstructured":"Kong JC, Soucisse M, Michael M, Tie J, Ngan SY, Leong T, et al. Total neoadjuvant therapy in locally advanced rectal cancer: A systematic review and metaanalysis of oncological and operative outcomes. Ann Surg Oncol. 2021;28(12):7476\u201386.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"15786_CR58","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1463-1318.2007.01417.x","volume":"10","author":"AA Khan","year":"2008","unstructured":"Khan AA, Wheeler JMD, Cunningham C, George B, Kettlewell M, Mortensen NJM. The management and outcome of anastomotic leaks in colorectal surgery. Colorectal Dis. 2008;10(6):587\u201392.","journal-title":"Colorectal Dis"},{"issue":"9","key":"15786_CR59","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1007\/s00464-019-07189-9","volume":"34","author":"ME Allaix","year":"2020","unstructured":"Allaix ME, Rebecchi F, Famiglietti F, Arolfo S, Arezzo A, Morino M. Long-term oncologic outcomes following anastomotic leak after anterior resection for rectal cancer: does the leak severity matter? Surg Endosc. 2020;34(9):4166\u201376.","journal-title":"Surg Endosc"},{"issue":"6","key":"15786_CR60","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10151-020-02153-5","volume":"24","author":"A Karim","year":"2020","unstructured":"Karim A, Cubas V, Zaman S, Khan S, Patel H, Waterland P. Anastomotic leak and cancer-specific outcomes after curative rectal cancer surgery: a systematic review and meta-analysis. Tech Coloproctol. 2020;24(6):513\u201325.","journal-title":"Tech Coloproctol"},{"issue":"6","key":"15786_CR61","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/SLA.0000000000000312","volume":"258","author":"RP Merkow","year":"2013","unstructured":"Merkow RP, Bentrem DJ, Mulcahy MF, Chung JW, Abbott DE, Kmiecik TE, et al. Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer. Ann Surg. 2013;258(6):847\u201353.","journal-title":"Ann Surg"},{"issue":"1","key":"15786_CR62","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1097\/SLA.0000000000005052","volume":"277","author":"PB Lynn","year":"2023","unstructured":"Lynn PB, Van der Valk MJM, Claassen YHM, Shi Q, Widmar M, Bastiaannet E, et al. Chemoradiation and local excision versus total mesorectal excision for T2N0 rectal cancer: Comparison of short- and long-term outcomes from 2 prospective studies. Ann Surg. 2023;277(1):e96\u2013102.","journal-title":"Ann Surg"},{"issue":"15","key":"15786_CR63","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/S1470-2045(15)00215-6","volume":"16","author":"J Garcia-Aguilar","year":"2015","unstructured":"Garcia-Aguilar J, Renfro LA, Chow OS, Shi Q, Carrero XW, Lynn PB, et al. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol. 2015;16(15):1537\u201346.","journal-title":"Lancet Oncol"},{"issue":"2","key":"15786_CR64","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ijrobp.2004.06.259","volume":"61","author":"NN Baxter","year":"2005","unstructured":"Baxter NN, Morris AM, Rothenberger DA, Tepper JE. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys. 2005;61(2):426\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"15786_CR65","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1200\/JCO.2002.07.010","volume":"20","author":"ID Nagtegaal","year":"2002","unstructured":"Nagtegaal ID, van de Velde CJH, van der Worp E, Kapiteijn E, Quirke P, van Krieken JHJM, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20(7):1729\u201334.","journal-title":"J Clin Oncol"},{"issue":"5","key":"15786_CR66","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1463-1318.2004.00670.x","volume":"6","author":"CC Thorn","year":"2004","unstructured":"Thorn CC, Woodcock NP, Scott N, Verbeke C, Scott SB, Ambrose NS. What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis. 2004;6(5):356\u201361.","journal-title":"Colorectal Dis"},{"issue":"9","key":"15786_CR67","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1001\/jamasurg.2023.2521","volume":"158","author":"Y Guzm\u00e1n","year":"2023","unstructured":"Guzm\u00e1n Y, R\u00edos J, Paredes J, Dom\u00ednguez P, Maurel J, Gonz\u00e1lez-Ab\u00f3s C, et al. Time interval between the end of neoadjuvant therapy and elective resection of locally advanced rectal cancer in the CRONOS study. JAMA Surg. 2023;158(9):910\u20139.","journal-title":"JAMA Surg"},{"issue":"7","key":"15786_CR68","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1245\/s10434-019-07340-9","volume":"26","author":"CSD Roxburgh","year":"2019","unstructured":"Roxburgh CSD, Strombom P, Lynn P, Gonen M, Paty PB, Guillem JG, et al. Role of the interval from completion of neoadjuvant therapy to surgery in postoperative morbidity in patients with locally advanced rectal cancer. Ann Surg Oncol. 2019;26(7):2019\u201327.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"15786_CR69","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0188-4409(03)00041-9","volume":"34","author":"P Luna-P\u00e9rez","year":"2003","unstructured":"Luna-P\u00e9rez P, Rodr\u00edguez-Ram\u00edrez S, Alvarado I, Guti\u00e9rrez de la Barrera M, Labastida S. Prognostic significance of retrieved lymph nodes per specimen in resected rectal adenocarcinoma after preoperative chemoradiation therapy. Arch Med Res. 2003;34(4):281\u20136.","journal-title":"Arch Med Res"},{"issue":"7","key":"15786_CR70","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/jclinpath-2016-203995","volume":"70","author":"Z Xu","year":"2017","unstructured":"Xu Z, Berho ME, Becerra AZ, Aquina CT, Hensley BJ, Arsalanizadeh R, et al. Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy. J Clin Pathol. 2017;70(7):584\u201392.","journal-title":"J Clin Pathol"},{"issue":"6","key":"15786_CR71","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00384-016-2747-7","volume":"32","author":"L Bustamante-Lopez Jr","year":"2017","unstructured":"Bustamante-Lopez L, Nahas CS, Nahas SC, Ribeiro U Jr, Marques CF, Cotti G, et al. Understanding the factors associated with reduction in the number of lymph nodes in rectal cancer patients treated by neoadjuvant treatment. Int J Colorectal Dis. 2017;32(6):925\u20137.","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"15786_CR72","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/bjs.9341","volume":"101","author":"R Persiani","year":"2014","unstructured":"Persiani R, Biondi A, Gambacorta MA, Bertucci Zoccali M, Vecchio FM, Tufo A, et al. Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer: Lymph node yield after neoadjuvant treatment for rectal cancer. Br J Surg. 2014;101(2):133\u201342.","journal-title":"Br J Surg"},{"issue":"3","key":"15786_CR73","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00384-016-2712-5","volume":"32","author":"F Runau","year":"2017","unstructured":"Runau F, Collins A, Fenech GA, Ford E, Dimitriou N, Chaudhri S, et al. A single institution\u2019s long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy. Int J Colorectal Dis. 2017;32(3):341\u20138.","journal-title":"Int J Colorectal Dis"},{"issue":"12","key":"15786_CR74","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.6004\/jnccn.2016.0164","volume":"14","author":"SRZ Abdel-Misih","year":"2016","unstructured":"Abdel-Misih SRZ, Wei L, Benson AB 3rd, Cohen S, Lai L, Skibber J, et al. Neoadjuvant therapy for rectal cancer affects lymph node yield and status without clear implications on outcome: The case for eliminating a metric and using preoperative staging to guide therapy. J Natl Compr Canc Netw. 2016;14(12):1528\u201334.","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"15786_CR75","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/DCR.0b013e31819eb872","volume":"52","author":"H Wang","year":"2009","unstructured":"Wang H, Safar B, Wexner S, Zhao R, Cruz-Correa M, Berho M. Lymph node harvest after proctectomy for invasive rectal adenocarcinoma following neoadjuvant therapy: does the same standard apply? Does the same standard apply? Dis Colon Rectum. 2009;52(4):549\u201357.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"15786_CR76","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1245\/s10434-016-5736-8","volume":"24","author":"K Vychnevskaia","year":"2017","unstructured":"Vychnevskaia K, Dumont F, Agostini J, Juli\u00e9 C, Dartigues P, Lazure T, et al. Prognostic value of sterilized lymph nodes after preoperative chemoradiotherapy for patients with ypN0 rectal cancer. Ann Surg Oncol. 2017;24(5):1304\u201311.","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"15786_CR77","doi-asserted-by":"publisher","first-page":"16975","DOI":"10.18632\/oncotarget.7703","volume":"7","author":"J Li","year":"2016","unstructured":"Li J, Yuan J, Liu H, Yin J, Liu S, Du F, et al. Lymph nodes regression grade is a predictive marker for rectal cancer after neoadjuvant therapy and radical surgery. Oncotarget. 2016;7(13):16975\u201384.","journal-title":"Oncotarget"},{"issue":"8","key":"15786_CR78","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.4251\/wjgo.v14.i8.1429","volume":"14","author":"L He","year":"2022","unstructured":"He L, Xiao J, Zheng P, Zhong L, Peng Q. Lymph node regression grading of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. World J Gastrointest Oncol. 2022;14(8):1429\u201345.","journal-title":"World J Gastrointest Oncol"},{"issue":"10","key":"15786_CR79","doi-asserted-by":"publisher","first-page":"O339","DOI":"10.1111\/codi.12682","volume":"16","author":"N Mirbagheri","year":"2014","unstructured":"Mirbagheri N, Kumar B, Deb S, Poh BR, Dark JG, Leow CC, et al. Lymph node status as a prognostic indicator after preoperative neoadjuvant chemoradiotherapy of rectal cancer. Colorectal Dis. 2014;16(10):O339\u201346.","journal-title":"Colorectal Dis"},{"issue":"4","key":"15786_CR80","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/codi.16929","volume":"26","author":"C McFeetors","year":"2024","unstructured":"McFeetors C, O\u2019Connell LV, Choy M, Dundon N, Regan M, Joyce M, et al. Influence of neoadjuvant treatment strategy on perioperative outcomes in locally advanced rectal cancer. Colorectal Dis. 2024;26(4):684\u201391.","journal-title":"Colorectal Dis"},{"issue":"7","key":"15786_CR81","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/DCR.0000000000002555","volume":"66","author":"Z Xu","year":"2023","unstructured":"Xu Z, Valente MA, Sklow B, Liska D, Gorgun E, Kessler H, et al. Impact of total neoadjuvant therapy on postoperative outcomes after proctectomy for rectal cancer. Dis Colon Rectum. 2023;66(7):1022\u20138.","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"15786_CR82","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/bjs\/znad094","volume":"17","author":"S van den Nordkamp","year":"2023","unstructured":"Nordkamp S, Piqeur F, van den Berg K, Tolenaar JL, van Hellemond IEG, Creemers G-J, et al. Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapy. Br J Surg. 2023;17(8):950\u20137.","journal-title":"Br J Surg"},{"issue":"7","key":"15786_CR83","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/bjs.8702","volume":"99","author":"ST Martin","year":"2012","unstructured":"Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012;99(7):918\u201328.","journal-title":"Br J Surg"},{"issue":"9","key":"15786_CR84","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","volume":"11","author":"M Maas","year":"2010","unstructured":"Maas M, Nelemans PJ, Valentini V, Das P, R\u00f6del C, Kuo L-J, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11(9):835\u201344.","journal-title":"Lancet Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15786-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15786-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15786-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:05:23Z","timestamp":1775574323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15786-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15786"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15786-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study reviewed and approved by Institutional Review Board at University Hospital Galway, approval reference number C.A. 2982. As all data was derived from a institutional oncology database and fully anonymised, individual written consent from patients was deemed not necessary by the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the manuscript and consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study conforms to the ethical principles set out in the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"446"}}